| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ca7a5b1506aaaaef0ca1a62cfd71228 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J63-008 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J63-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 |
| filingDate |
2017-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4c96ccf9d7092f9016e3877e0209884
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b22f23335be2aab225b0be0c0964f7ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a910e0469dd55addf42d1b9402231be6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a70bf0ac290bb7ae8258f6e04d56acc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afe9903bd4c6fcdb110fbe055de9be53 |
| publicationDate |
2018-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-107812009-A |
| titleOfInvention |
Application and preparation method of triterpene saponins |
| abstract |
The invention belongs to the technical field of medicines, and in particular relates to the application and preparation method of a triterpene saponin compound. For the preparation of medicines for the treatment of fungal infections; have the following chemical structure: . The present invention also provides a preparation method thereof, which systematically separates Sapindus and screens out two kinds of triterpene saponins described in the present invention. The antifungal mechanism is clear, and the antifungal effect is obviously better than other Sapindus total saponins and Sapindus saponins. Saponin A, Sapindus saponin B and Clemontanoside C. It is equivalent to the current mainstream drugs in the market, and its effect on Candida capsularis is obviously better than that of the mainstream drugs in the market. It has the advantages of clear mechanism, definite curative effect, and easy industrial production. An infection caused by Candida. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108403751-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110168093-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110168093-B |
| priorityDate |
2017-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |